Cargando…
Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme
BACKGROUND: Currently, the predominant onchocerciasis control strategy in Africa is annual mass drug administration (MDA) with ivermectin. However, there is a consensus among the global health community, supported by mathematical modelling, that onchocerciasis in Africa will not be eliminated within...
Autores principales: | Turner, Hugo C., Walker, Martin, Lustigman, Sara, Taylor, David W., Basáñez, María-Gloria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506122/ https://www.ncbi.nlm.nih.gov/pubmed/26186715 http://dx.doi.org/10.1371/journal.pntd.0003938 |
Ejemplares similares
-
Uncertainty Surrounding Projections of the Long-Term Impact of Ivermectin Treatment on Human Onchocerciasis
por: Turner, Hugo C., et al.
Publicado: (2013) -
The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data
por: Turner, Hugo C, et al.
Publicado: (2015) -
The Onchocerciasis Vaccine for Africa—TOVA—Initiative
por: Hotez, Peter J., et al.
Publicado: (2015) -
Economic evaluations of onchocerciasis interventions: a systematic review and research needs
por: Turner, Hugo C., et al.
Publicado: (2019) -
From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes
por: Colebunders, Robert, et al.
Publicado: (2019)